Journal articles

2019

ref_biblio

Sercan Deniz, Eric Wersinger, Serge Picaud, Michel J Roux. Evidence for functional GABAA but not GABAC receptors on mouse cone photoreceptors. Visual Neuroscience, 2019, 36, pp.E005. ⟨10.1017/S0952523819000038⟩. ⟨hal-02342212⟩

Accès au texte intégral et bibtex

2018

ref_biblio

Frederic Venail, Pierre Attali, Eric Wersinger, Roberto Gomeni, Sonia Maria Poli, et al.. Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H 4 receptor inhibitor SENS-111 using a modified caloric test in healthy subjects. British Journal of Clinical Pharmacology, 2018, 84 (12), pp.2836-2848. ⟨10.1111/bcp.13744⟩. ⟨hal-02315424⟩

Accès au bibtex

2016

ref_biblio

P. Attali, R. Gomeni, E. Wersinger, S. Poli, F. Venail. The Effects of SENS-111, A New H4R Antagonist, On Vertigo Induced by Caloric Test in Healthy Volunteers (HV) is Related to Plasma Concentrations. Clinical Therapeutics, 2016, 38 (10S), pp.e4. ⟨10.1016/j.clinthera.2016.07.024⟩. ⟨hal-01818970⟩

Accès au bibtex

2011

ref_biblio

Sercan Deniz, Eric Wersinger, Yannick Schwab, Carole Mura, Ferenc Erdelyi, et al.. Mammalian retinal horizontal cells are unconventional GABAergic neurons. Journal of Neurochemistry, 2011, 116 (3), pp.350-362. ⟨10.1111/j.1471-4159.2010.07114.x⟩. ⟨hal-04286685⟩

Accès au bibtex

2006

ref_biblio

Eric Wersinger, Yannick Schwab, José-Alain Sahel, Alvaro Rendon, David Pow, et al.. The glutamate transporter EAAT5 works as a presynaptic receptor in mouse rod bipolar cells. The Journal of Physiology, 2006, 577 (1), pp.221-234. ⟨10.1113/jphysiol.2006.118281⟩. ⟨hal-04098634⟩

Accès au bibtex

Poster communications

2022

ref_biblio

M. Morez, L. Prival, Y. Aissouni, E. Bourinet, O. Roy, et al.. Disrupting HCN channels - TRIP8b interaction is an efficient strategy to decrease acute oxaliplatin-induced peripheral neuropathy symptoms.. IASP 2022 World Congress on pain, Sep 2022, Toronto, Canada. ⟨hal-04068893⟩

Accès au bibtex

Proceedings

2022

ref_biblio

M. Morez, Y. Aissouni, L. Prival, J. Barbier, D. Balayssac, et al.. Modulation of HCN channel activity in oxaliplatin-induced peripheral neuropathy.. Fundamental & Clinical Pharmacology, 36 (S1), pp.10-11, 2022, ⟨10.1111/fcp.12786⟩. ⟨hal-04026980⟩

Accès au bibtex